Larvol Delta - A-Study-on-Paxlovid-Once-in-the-Market-to-Observe-Its-Safety-and-Effectiveness-in-Patients-Who-Have-a-High-Chance-of-Getting-Severe-COVID19

Paxlovid (nirmatrelvir/ritonavir) - Pfizer

http://clinicaltrials.gov/ct2/show/NCT05890612

Aug 13, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next